de Boever CM - Search Results

1

Vitamin E supplementation increases the expression of the CCR5 coreceptor in HIV-1 infected subjects.

Portales P, Guerrier T, Clot J, Corbeau P, Mettling C, Lin YL, Baillat V, de Boever CM, Le Moing V, Tramoni C, Reynes J, Segondy M. Portales P, et al. Among authors: de boever cm. Clin Nutr. 2004 Oct;23(5):1244-5. doi: 10.1016/j.clnu.2004.07.021. Clin Nutr. 2004. PMID: 15380918 No abstract available.

2

Small dense LDL and atherogenic lipid profile in HIV-positive adults: influence of lopinavir/ritonavir-containing regimen.

Badiou S, De Boever CM, Dupuy AM, Baillat V, Cristol JP, Reynes J. Badiou S, et al. Among authors: de boever cm. AIDS. 2003 Mar 28;17(5):772-4. doi: 10.1097/00002030-200303280-00023. AIDS. 2003. PMID: 12646808 No abstract available.

3

T-Cell surface CCR5 density is not correlated with hepatitis severity in hepatitis C virus/HIV-coinfected individuals: implications for the therapeutic use of CCR5 antagonists.

Vincent T, Portales P, Baillat V, de Boever CM, Le Moing V, Vidal M, Ducos J, Clot J, Reynes J, Corbeau P. Vincent T, et al. Among authors: de boever cm. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):305-9. J Acquir Immune Defic Syndr. 2005. PMID: 15735449

4

CXCR4 overexpression during the course of HIV-1 infection correlates with the emergence of X4 strains.

Lin YL, Portales P, Segondy M, Baillat V, de Boever CM, Le Moing V, Réant B, Montes B, Clot J, Reynes J, Corbeau P. Lin YL, et al. Among authors: de boever cm. J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):530-6. J Acquir Immune Defic Syndr. 2005. PMID: 16044003

5

Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?

Badiou S, De Boever CM, Terrier N, Baillat V, Cristol JP, Reynes J. Badiou S, et al. Among authors: de boever cm. J Infect. 2006 May;52(5):335-8. doi: 10.1016/j.jinf.2005.07.020. Epub 2005 Sep 19. J Infect. 2006. PMID: 16176835 Clinical Trial.

6

Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.

Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, Rosenthal E, Jougla E, Cacoub P, Salmon D, Chêne G, Morlat P; Agence Nationale de Recherches sur le Sida et les Hépatites Virales EN19 Mortalité Study Group; Mortavic Study Group. Bonnet F, et al. Clin Infect Dis. 2009 Mar 1;48(5):633-9. doi: 10.1086/596766. Clin Infect Dis. 2009. PMID: 19202627

7

Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.

Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C; ANRS COPANA Cohort Study Group. Boufassa F, et al. Antivir Ther. 2012;17(1):91-100. doi: 10.3851/IMP1916. Antivir Ther. 2012. PMID: 22267473 Free PMC article.

8

Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.

Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, Carlier R, Capeau J, Goujard C, Meyer L, Viard JP; ANRS-COPANA Cohort Study Group. Legeai C, et al. PLoS One. 2013 Sep 18;8(9):e74868. doi: 10.1371/journal.pone.0074868. eCollection 2013. PLoS One. 2013. PMID: 24058636 Free PMC article.

9

Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.

Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration. Lodi S, et al. Lancet HIV. 2015 Aug;2(8):e335-43. doi: 10.1016/S2352-3018(15)00108-3. Epub 2015 Jul 7. Lancet HIV. 2015. PMID: 26423376 Free PMC article.

10

Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patients.

Le Moing V, Peytavin G, Journot V, Cottalorda J, Bouvet E, Chêne G, Préau M, de Boever CM, Leport C, Raffi F; Antiprotease Cohort (APROCO) Study Group. Le Moing V, et al. Among authors: de boever cm. J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):497-9. doi: 10.1097/00126334-200312150-00008. J Acquir Immune Defic Syndr. 2003. PMID: 14657760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters